Watch the Webinar
On Demand
Making Formulation Decisions You Can Defend in Late-Stage Biologics
Real-world insights from a late-stage biologics program at Akero, now part of Novo Nordisk.
Watch the Webinar On Demand
Fill out the form to access the full webinar recording. After submitting the form, you will be redirected directly to the replay page.
Why this matters now
As biologics programs move toward commercialization, formulation decisions become increasingly complex. Teams need to balance speed, robustness, scalability and long-term product strategy while generating data that supports decisions they can defend.
In this on-demand webinar, Leukocare and Akero discuss how structured, data-driven formulation development can help build confidence in critical late-stage decisions.
More data alone does not automatically create confidence.
What you’ll learn
Who should attend?
Real-world insights.
Practical perspectives.
A conversation between Leukocare and Akero, now part of Novo Nordisk, bringing together a late-stage biologics development perspective and an industry expert in formulation strategy and experimental design.
development perspective
Experience from a late-stage program in biologics development — bringing a practitioner's view on formulation decisions under real commercial pressure.
Expert in formulation strategy, DoE and data-driven decision making for biologics programs at all development stages.